AS
Aniruddha Singh
About Aniruddha Singh
Data last updated:
Aniruddha Singh is a Director at Enzene Biosciences Limited (since 2025), Director at Adroit Biomed Limited (since 2025) and Individual Subscriber at Alkem Wellness Limited (since 2024), and holds 5 more current directorships. The companies operate in Life Sciences, FMCG and Paper. The 4 current companies with reported revenue have a combined latest revenue of ₹439 Cr; the largest is Enzene Biosciences Limited at ₹385 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Enzene Biosciences Limited U24232PN2006PLC165610 | Director | 07 Mar 2025 | 2006 | ₹385 Cr (FY 2025) | Active |
 Adroit Biomed Limited U22100MH2009PLC197761 | Director | 26 May 2025 | 2009 | ₹53.89 Cr (FY 2024) | Active |
 Alkem Wellness Limited U21002MH2024PLC432206 | Individual Subscriber | 16 Sep 2024 | 2024 | ₹6.3 Lakh (FY 2025) | Active |
| Maaiya Social Change Front Foundation U85300MH2021NPL358494 | Director | 07 Apr 2021 | 2021 | ₹1.7 Lakh (FY 2025) | Active |
| Alixer Nexgen Therapeutics Limited U21001MH2024PLC428703 | Individual Subscriber | 12 Jul 2024 | 2024 | Active | |
| Alkem Medtech Private Limited U32509MH2024PTC422195 | Whole-Time Director | 27 Mar 2024 | 2024 | Active | |
| Lunavista Realty Private Limited U68200MH2023PTC411058 | Director | 25 Sep 2023 | 2023 | Active | |
| Prospera Ventures Private Limited U46901MH2023PTC407016 | Director | 20 Jul 2023 | 2023 | Active |
Board colleagues of Aniruddha Singh
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aniruddha Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aniruddha Singh
Aniruddha Singh currently holds 8 directorships: Enzene Biosciences Limited (Director, since 07 Mar 2025, revenue ₹385 Cr (FY 2025)); Adroit Biomed Limited (Director, since 26 May 2025, revenue ₹53.89 Cr (FY 2024)); Alkem Wellness Limited (Individual Subscriber, since 16 Sep 2024, revenue ₹6.3 Lakh (FY 2025)); Maaiya Social Change Front Foundation (Director, since 07 Apr 2021, revenue ₹1.7 Lakh (FY 2025)); Alixer Nexgen Therapeutics Limited (Individual Subscriber, since 12 Jul 2024); and 3 more.
Aniruddha Singh was first appointed on 07 Apr 2021 as Director at Maaiya Social Change Front Foundation. The most recent appointment on record is 26 May 2025 at Adroit Biomed Limited.
The 4 current companies of Aniruddha Singh that report revenue have a combined latest revenue of ₹439 Cr: Enzene Biosciences Limited ₹385 Cr (FY 2025); Adroit Biomed Limited ₹53.89 Cr (FY 2024); Alkem Wellness Limited ₹6.3 Lakh (FY 2025); Maaiya Social Change Front Foundation ₹1.7 Lakh (FY 2025).
The current boards of Aniruddha Singh's companies include Himanshu Shashikant Gadgil (Enzene Biosciences Limited), Himanshu Shashikant Gadgil (Enzene Biosciences Limited), Nilesh Ambani (Enzene Biosciences Limited), Prem Venkatachalam Pavoor (Enzene Biosciences Limited), Sandeep Singh (Enzene Biosciences Limited), Sangeeta Kapil Jit Singh (Enzene Biosciences Limited), among others.